Home
Immix Biopharma IMMX paid Tarplin, Downs & Young $20K for lobbying in Q1 2026 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $20,000
- Quarter
- Q1 2026
- Stock
- Immix Biopharma IMMX
- Client
- Immix Biopharma
- Reported
- 26/04/20
First lobbying report
What else happened in Immix Biopharma around then
Filed or reported within 30 days of the trade day · 03/01~04/30Immix Biopharma's other lobbying reports
- Immix Biopharma
LobbyingImmix Biopharma
LobbyingImmix Biopharma
IMMX
$20K
$20K
Reported 07/20
for Q2
- Immix Biopharma
LobbyingImmix Biopharma
LobbyingImmix Biopharma
IMMX
$105K
$105K
Reported 07/19
for Q2
- Immix Biopharma
LobbyingImmix Biopharma
LobbyingImmix Biopharma
IMMX
$20K
$20K
Reported 07/17
for Q2
- Immix Biopharma
LobbyingImmix Biopharma
LobbyingImmix Biopharma
IMMX
$50K
$50K
Reported 04/20
for Q1